Zhulin Yin - 3Institute of Cancer Research

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

MC-Keyboard: A Practical Phase I Trial Design for Targeted Therapies and Immunotherapies Integrating Multiple-Grade Toxicities

Liyun Jiang,Zhulin Yin,Fangrong Yan,Ying Yuan

Journal of Immunotherapy and Precision Oncology (2024)

引用0浏览0WOS引用

Handling Incomplete or Late-Onset Toxicities in Early-Phase Dose-Finding Clinical Trials: Current Practice and Future Prospects

Zhulin Yin,Adrian P Mander,Johann S de Bono,Haiyan Zheng,Christina Yap

JCO precision oncology (2024): e2300441-e2300441

引用0浏览0WOS引用

Proof-of-concept and Preliminary Efficacy of Triple IAP Blockade to Maximize Immunogenic Cell Death and Induce Efficient Adaptive Immune Response: First Report on the ASTEROID Phase 1 Trial

Crescens Tiu, Wing Yau, Victoria Sanchez-Perez,Giovanni Codacci-Pisanelli, Ching Leung, Eden S. Andrews,Bristi Basu,Anna Zachariou,Toby Prout,Mona Parmar,Alison Turner,Xiaoran Lai,Zhulin Yin,Karen E. Swales,Syed Haider, Thomas Lund, Diego C. Dos Reis, Tatiany L. Silveira, Alan S. Dunlop,Ann-Marie Baker,Bora Gurel, Ana Ferreira,Claudia Bertan,Nina Tunariu,Edward W. Johnston,Alistair Ring,Tencho Tenev,Tomoko Smyth,Simone Jueliger,Udai Banerji,Johann S. de Bono,Alec Paschalis,Adam Sharp,Anna Minchom,Christina Yap,Pascal Meier,Juanita S. Lopez

CANCER RESEARCHno. 7 (2024)

引用0浏览0引用

Assessing the Reporting Quality of Early Phase Dose-Finding Trial Protocols: A Methodological Study

Guillermo Villacampa Javierre,Dhrusti Patel,Haiyan Zheng,Jessica McAleese,Jan Rekowski,Olga Solovyeva,Zhulin Yin,Christina Yap

crossref（2023）

引用0浏览0引用

Assessing the reporting quality of early phase dose-finding trial protocols: a methodological reviewResearch in context

Guillermo Villacampa,Dhrusti Patel,Haiyan Zheng,Jessica McAleese,Jan Rekowski,Olga Solovyeva,Zhulin Yin,Christina Yap

EClinicalMedicine (2023): 102020

引用0浏览0引用

37P Dose Transition Pathways for Time-to-event Continual Reassessment Method (TITE-CRM): Will Imposing a Waiting Time Result in Better Performance

C. Yap,Z. Yin,S. Lee, K. Cheung

ESMO open（2023）

引用0浏览0引用

Assessing the reporting quality of early phase dose-finding trial protocols: a methodological review

Guillermo Villacampa,Dhrusti Patel,Haiyan Zheng,Jessica McAleese,Jan Rekowski,Olga Solovyeva,Zhulin Yin,Christina Yap

ECLINICALMEDICINE (2023): 102020-102020

引用3浏览0WOS引用

Implementation of Platform Trials in the COVID-19 Pandemic: A Rapid Review

Alyssa M. Vanderbeek,Judith M. Bliss,Zhulin Yin,Christina Yap

CONTEMPORARY CLINICAL TRIALS（2022）

引用17浏览0引用

53P Assessing the reporting quality of early phase dose-finding trials

C. Yap,O. Solovyeva,Z. Yin,J. Martin, T. Manickavasagar,C. Weir,S. Lee,M. Dimairo, R. Liu, A. Kightley,J.S. de Bono

Annals of Oncology (2022): S24-S24

引用6浏览0引用

Trends in patient-reported outcome use in early phase dose-finding oncology trials - an analysis of ClinicalTrials.gov

Julia Lai-Kwon,Zhulin Yin,Anna Minchom,Christina Yap

CANCER MEDICINE（2021）

引用9浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn